<DOC>
	<DOCNO>NCT01786486</DOCNO>
	<brief_summary>The objective AMPLATZER Cardiac Plug ( ACP ) Registry Long Term Follow-up study evaluate long term performance ACP closure Left Atrial Appendage ( LAA ) subject nonvalvular atrial fibrillation assess adverse event two ( 2 ) year post implant .</brief_summary>
	<brief_title>AMPLATZER Cardiac Plug ( ACP ) Registry-Long Term Follow-up Protocol</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Subject must document history paroxysmal , persistent permanent nonvalvular atrial fibrillation ( documentation may include electrocardiogram ( ECG ) , Holter , event recorder ) Subject must â‰¥18 year age Subject implant atrial septal defect ( ASD ) device patent foramen ovale ( PFO ) device Subject history surgical ASD PFO repair Subject history stroke unrepaired PFO Subject moderate severe aortic mitral valve stenosis regurgitation assess investigator Subject mitral aortic prosthetic valve Subject plan ablation procedure atrial fibrillation 30 day ACP implant Subject New York Heart Association ( NYHA ) grade 4 Subject evidence pericardial effusion baseline evaluation Subject complex atheroma mobile plaque descend aorta and/or aortic arch Subject intracardiac thrombus Subject carotid disease assess investigator , require treatment , include revascularization and/or medical treatment Subject active infection active endocarditis Subject acute recent myocardial infarction ( MI ) unstable angina ( recent define within 6 month implant date ) Subject recent major cardiac surgical procedure ( recent define within 6 month implant date ) Subject malignancy illness life expectancy le one year Subject pregnant , breastfeeding , desire become pregnant first six month followup Subject legally authorize representative unable provide inform consent Subject able follow duration clinical study Subject medical disorder severe disability would interfere completion evaluation clinical study result ( e.g . uncontrolled hypertension , uncontrolled diabetes , renal failure , situ inferior vena cava ( IVC ) filter )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>